Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Obstr Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01494610
What this trial is testing

Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.

Who this might be right for
Asthma
GlaxoSmithKline 60
Not applicableStudy completedNCT02172521
What this trial is testing

Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 1,536
Not applicableUnknownNCT06503315
What this trial is testing

Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sohag University 70
Not applicableUnknownNCT06436482
What this trial is testing

Research of Endobronchial Optical Coherence Tomography in Pre-COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseOptical Coherence TomographyPulmonary Function
Sichuan Provincial People's Hospital 80
Early research (Phase 1)Study completedNCT03235726
What this trial is testing

Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 52
Not applicableStudy completedNCT01263340
What this trial is testing

Characterisation of People With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
National Services for Health Improvement Ltd 10,000
Post-approval studies (Phase 4)Study completedNCT02429050
What this trial is testing

Morphine for Treatment of Dyspnea in Patients With COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Maastricht University Medical Center 124
Not applicableStudy completedNCT02231320
What this trial is testing

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 236
Not applicableStudy completedNCT03264924
What this trial is testing

Improving Physical Activity in Rehabilitation

Who this might be right for
Cardiovascular DiseasesPulmonary DiseaseChronic Obstructive Pulmonary Disease
Liverpool Heart and Chest Hospital NHS Foundation Trust 82
Not applicableStudy completedNCT02114515
What this trial is testing

PATient Navigator to rEduce Readmissions

Who this might be right for
Chronic Obstructive Pulmonary DiseaseHeart FailureSickle Cell Disease+2 more
University of Illinois at Chicago 1,029
Not applicableUnknownNCT03692117
What this trial is testing

Extracorporeal Carbon Dioxide Removal in Severe Chronic Obstructive Pulmonary Disease Exacerbation

Who this might be right for
COPD Exacerbation
China-Japan Friendship Hospital 30
Not applicableStudy completedNCT06308289
What this trial is testing

Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Riphah International University 68
Not applicableStudy completedNCT06432920
What this trial is testing

A Wearable In-phase Chest Wall Vibration Device for Relief of Dyspnoea in COPD: a First-in-human Exploratory Study

Who this might be right for
Chronic Obstructive Pulmonary DiseaseDyspnea
Elevre Medical Ltd. 20
Not applicableStudy completedNCT04363723
What this trial is testing

The Influence of an Acute Exacerbation During Pulmonary Rehabilitation in COPD Patients Awaiting Lung Transplantation

Who this might be right for
Chronic Obstructive Pulmonary Disease
Klaus Kenn 559
Post-approval studies (Phase 4)Study completedNCT01943552
What this trial is testing

Ipratropium Bromide in Peri-Operative COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 192
Not applicableUnknownNCT04008017
What this trial is testing

Eosinophilic Cationic Protein as a Biomarker in Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
Assiut University 64
Early research (Phase 1)Study completedNCT01690949
What this trial is testing

Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Pulmatrix Inc. 24
Post-approval studies (Phase 4)Study completedNCT02450968
What this trial is testing

Altitude Related Illness In Patients With Respiratory Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
University of Zurich 124
Very early researchLooking for participantsNCT07355868
What this trial is testing

Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Regend Therapeutics 12
Large-scale testing (Phase 3)Study completedNCT00929110
What this trial is testing

1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis 1,066
Next Page